Marshall Wace’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $697K | Sell |
39,914
-116,721
| -75% | -$2.04M | ﹤0.01% | 1883 |
|
|
2025
Q1 | $1.97M | Buy |
156,635
+103,729
| +196% | +$1.3M | ﹤0.01% | 1378 |
|
|
2024
Q4 | $558K | Sell |
52,906
-24,973
| -32% | -$263K | ﹤0.01% | 1859 |
|
|
2024
Q3 | $1.13M | Buy |
+77,879
| New | +$1.13M | ﹤0.01% | 1481 |
|
|
2023
Q3 | – | Sell |
-74,621
| Closed | -$500K | – | 2289 |
|
|
2023
Q2 | $500K | Buy |
74,621
+35,193
| +89% | +$236K | ﹤0.01% | 1588 |
|
|
2023
Q1 | $257K | Buy |
39,428
+7,417
| +23% | +$48.3K | ﹤0.01% | 1865 |
|
|
2022
Q4 | $273K | Buy |
+32,011
| New | +$273K | ﹤0.01% | 2011 |
|
|
2021
Q4 | – | Sell |
-275,567
| Closed | -$2.75M | – | 3561 |
|
|
2021
Q3 | $2.75M | Buy |
+275,567
| New | +$2.75M | 0.01% | 1076 |
|